These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 26783575)

  • 1. Response.
    Kanda T; Matsuda M; Toyoda K; Furui S
    Radiology; 2015 Aug; 276(2):616. PubMed ID: 26783575
    [No Abstract]   [Full Text] [Related]  

  • 2. Relaxometry of dextran and albumin labeled with Gd-chelates.
    Niemi P; Reisto T; Kormano M
    Invest Radiol; 1991 Nov; 26 Suppl 1():S48-9; discussion S60-4. PubMed ID: 1725520
    [No Abstract]   [Full Text] [Related]  

  • 3. Detecting and measuring free gadolinium in nanoparticles for MRI imaging.
    Clogston JD; Patri AK
    Methods Mol Biol; 2011; 697():101-8. PubMed ID: 21116958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium released from MR contrast agents is deposited in brain tumors: in situ demonstration using scanning electron microscopy with energy dispersive X-ray spectroscopy.
    Xia D; Davis RL; Crawford JA; Abraham JL
    Acta Radiol; 2010 Dec; 51(10):1126-36. PubMed ID: 20868305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadolinium deposition in nephrogenic fibrosing dermopathy.
    Boyd AS; Zic JA; Abraham JL
    J Am Acad Dermatol; 2007 Jan; 56(1):27-30. PubMed ID: 17109993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis.
    High WA; Ayers RA; Chandler J; Zito G; Cowper SE
    J Am Acad Dermatol; 2007 Jan; 56(1):21-6. PubMed ID: 17097388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of gadolinium-based MRI contrast agents in biological and environmental samples: a review.
    Telgmann L; Sperling M; Karst U
    Anal Chim Acta; 2013 Feb; 764():1-16. PubMed ID: 23374209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relaxivity of gadolinium complexes detected by atomic magnetometry.
    Michalak DJ; Xu S; Lowery TJ; Crawford CW; Ledbetter M; Bouchard LS; Wemmer DE; Budker D; Pines A
    Magn Reson Med; 2011 Aug; 66(2):605-8. PubMed ID: 21433067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporation of excess gadolinium into human bone from medical contrast agents.
    Darrah TH; Prutsman-Pfeiffer JJ; Poreda RJ; Ellen Campbell M; Hauschka PV; Hannigan RE
    Metallomics; 2009 Nov; 1(6):479-88. PubMed ID: 21305156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatographic determination of the magnetic resonance imaging contrast agent gadobenate ion in plasma, urine, faeces, bile and tissues.
    Arbughi T; Bertani F; Celeste R; Grotti A; Sillari S; Tirone P
    J Chromatogr B Biomed Sci Appl; 1998 Aug; 713(2):415-26. PubMed ID: 9746258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The developmental history of the gadolinium chelates as intravenous contrast media for magnetic resonance.
    Runge VM; Ai T; Hao D; Hu X
    Invest Radiol; 2011 Dec; 46(12):807-16. PubMed ID: 22094366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergic reactions to gadolinium chelates.
    Runge VM
    AJR Am J Roentgenol; 2001 Oct; 177(4):944-5. PubMed ID: 11566710
    [No Abstract]   [Full Text] [Related]  

  • 13. Time-dependent decrement of dermal gadolinium deposits and significant improvement of skin symptoms in a patient with nephrogenic systemic fibrosis after temporary renal failure.
    Schäd SG; Heitland P; Kühn-Velten WN; Gross GE; Jonas L
    J Cutan Pathol; 2013 Nov; 40(11):935-44. PubMed ID: 24102613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation.
    Errante Y; Cirimele V; Mallio CA; Di Lazzaro V; Zobel BB; Quattrocchi CC
    Invest Radiol; 2014 Oct; 49(10):685-90. PubMed ID: 24872007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for the covalent conjugation of a bifunctional chelating agent to albumin: synthesis and characterization of potential MRI contrast agents.
    Kundu A; Peterlik H; Krssak M; Bytzek AK; Pashkunova-Martic I; Arion VB; Helbich TH; Keppler BK
    J Inorg Biochem; 2011 Feb; 105(2):250-5. PubMed ID: 21194625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of gadolinium chelates as an alternative radiographic contrast agent for use with flat panel detector angiography.
    Hui FK; Tong FC; Dion JE
    J Neurointerv Surg; 2011 Mar; 3(1):95-7. PubMed ID: 21990800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte-directed MR contrast agents. Can we take advantage of bile acids?
    Anelli PL; Calabi L; de Haën C; Lattuada L; Lorusso V; Maiocchi A; Morosini P; Uggeri F
    Acta Radiol Suppl; 1997; 412():125-33. PubMed ID: 9240091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More on pseudohypocalcemia and gadolinium-enhanced MRI.
    Prince MR; Choyke PL; Knopp MV
    N Engl J Med; 2004 Jan; 350(1):87-8; author reply 87-8. PubMed ID: 14702437
    [No Abstract]   [Full Text] [Related]  

  • 19. Magnetic resonance imaging and acupuncture: a feasibility study on the migration of tracers after injection at acupoints of small animals.
    Kim J; Bae KH; Hong KS; Han SC; Soh KS
    J Acupunct Meridian Stud; 2009 Jun; 2(2):152-8. PubMed ID: 20633487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gadolinium chelating agents for arteriography and CT x-ray].
    Trillaud H
    J Radiol; 2002 Nov; 83(11):1715-6. PubMed ID: 12469008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.